Association between serum adipocytokine levels and microangiopathies in patients with type 2 diabetes mellitus

Journal of Diabetes Investigation

Volumn 5, Issue 3, 2014, Pages 333-339

  Jung, Chan Hee ^a   Kim, Bo Yeon ^a   Mok, Ji Oh ^a   Kang, Sung Koo ^a   Kim, Chul Hee ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Adipocytokines; Diabetic microangiopathies

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APOLIPOPROTEIN B; C PEPTIDE; C REACTIVE PROTEIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; ARTICLE; BODY MASS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE; HUMAN; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; SYSTOLIC BLOOD PRESSURE;

EID: 84899913239     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12144     Document Type: Article

References (37)

1. Meier U, Gressner AM. Endocrine regulation of energy metabolism. Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50: 1511-1525.
2. Matsuda M, Shimomura I, Sato M, et al. Role of adiponectin in preventing vascular stenosis. J Biol Chem 2002; 277: 27487-27491.
3. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
4. Matsuda M, Kawasaki F, Inoue H, et al. Possible contribution of adipocytokines on diabetic neuropathy. Diabetes Res Clin Pract 2004; 66: S121-S123.
5. Looker HC, Krakoff J, Funahashi T, et al. Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 4010-4017.
6. Ran J, Xiong X, Liu W, et al. Increased plasma adiponectin closely associates with vascular endothelial dysfunction in type 2 diabetic patients with diabetic nephropathy. Diabetes Res Clin Pract 2010; 88: 177-183.
7. Kato K, Osawa H, Ochi M, et al. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy. Clin Endocrinol 2008; 68: 442-449.
8. Yilmaz MI, Sonmez A, Acikel C, et al. Adiponectin may play a part in the pathogenesis of diabetic retinopathy. Eur J Endocrinol 2004; 151: 135-140.
9. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentration in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
10. Krasnodebski P, Bak MI, Opolski G, et al. Leptin in acute myocardial infarction and period of convalescence in patients with type 2 diabetes mellitus. Kardiol Pol 2010; 68: 648-653.
11. Sari R, Balci MK, Apaydin C. The relationship between plasma leptin levels and chronic complications in patients with type 2 diabetes mellitus. Metab Syndr Relat Disord 2010; 8: 499-503.
12. Freuhwald-Schultes B, Kern W, Beyer J, et al. Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria. Metabolism 1999; 48: 1290-1293.
13. Uckaya G, Ozata M, Bayraktar Z, et al. Is leptin associated with diabetic retinopathy? Diabetes Care 2000; 23: 371-376.
14. Mariano F, Bussolati B, Piccoli G, et al. Renal vascular effects of cytokines. Blood Purif 1997; 15: 262-272.
15. Flyvbjerg A. Diabetic angiopathy, the complement system and tumor necrosis factor superfamily. Nat Rev Endocrinol 2010; 6: 94-101.
16. Navarro JF, Mora C, Macia M, et al. Inflammatory parameters are independently associated with urinary albumin excretion in type 2 diabetes mellitus. Am J Kidney Dis 2003; 42: 53-61.
17. Hasegawa G, Nakano K, Sawada M, et al. Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int 1991; 40: 1007-1012.
18. Zorena K, Mysliwska J, Mysliwiec M, et al. Serum TNF-α level predicts nonproliferative diabetic retinopathy in children. Mediators Inflamm 2007; 2007: 92196-92200.
19. Jung CH, Kim BY, Kim CH, et al. Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients. Cardiovasc Diabetol 2012; 11: 24.
20. National Glycohemoglobin Standardization Program (NGSP): List of NGSP certified methods. Available at: http://www.ngsp.org/docs/methods.pdf [accessed 2011, August 10].
21. Watkins PJ. ABC of diabetes; retinopathy. British Med J 2003; 326: 924-926.
22. Expert Committee of Korean Diabetes Neuropathy Study Group. Diabetic neuropathy management guidebook, 3rd edn. Gold Planning and Development, Seoul, 2010. (Korean).
23. Chun SW, Ko KS. Summary of the update to the diabetic neuropathy management guidebook. J Korean Diabetes 2012; 13: 115-123 (Korean).
24. Feldman EL, Stevens MJ, Thomas PK, et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281-1289.
25. Pitei DL, Watkins PJ, Stevens MJ, et al. The value of the Neurometer in assessing diabetic neuropathy by measurement of the current perception threshold. Diabet Med 1994; 11: 872-876.
26. Imagawa A, Funahashi T, Nakamura T, et al. Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 2002; 25: 1665-1666.
27. Zhang W, Liu H, Al-Shabrawey M, et al. Inflammation and diabetic retinal microvascular complications. J Cardiovasc Dis Res 2011; 2: 96-103.
28. Saito T, Saito O, Kawano T, et al. Elevation of serum adiponectin and CD146 levels in diabetic nephropathy. Diabetes Res Clin Pract 2007; 78: 85-92.
29. Hosokawa Y, Yamada Y, Obata Y, et al. Relationship between serum cystatin C and serum adiponectin level in type 2 diabetic patients. Clin Exp Nephrol 2012; 16: 399-405.
30. Lin J, Hu EB, Curhan G. Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabetes Care 2007; 30: 239-244.
31. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003; 148: 293-300.
32. Bjaj M, Suraamornkul S, Piper P, et al. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 2004; 89: 200-206.
33. Perelas A, Tsoulkani K, Perrea D. Effects of lipid-lowering drugs on adiponectin. Curr Vasc Pharmacol 2010; 8: 836-848.
34. Asakawa H, Tokunaga K, Kawakami F. Relationship of leptin level with metabolic disorders and hypertension in Japanese type 2 diabetes mellitus patients. J Diabetes Complications 2001; 15: 57-62.
35. Meyer C, Robson D, Rackovsky N, et al. Role of the kidney in human leptin metabolism. Am J Physiol 1997; 273: E903-E907.
36. Sharma K, Considine RV, Michael B, et al. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 1997; 51: 1980-1985.
37. Jung CH, Rhee EJ, Choi JIH, et al. The relationship of adiponectin/leptin ratio with homeostasis model assessment insulin resistance index and metabolic syndrome in apparently healthy Korean male adults. Diabet Metab J 2010; 34: 237-243.